Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.
The introduction of routine infant immunization with Haemophilus influenzae type b (Hib) conjugate vaccines in the United Kingdom in 1992 led to a significant reduction in invasive disease due to this organism. Subsequently, between 1999 and 2003 there was an increase in the number of immunized chil...
Main Authors: | Kelly, D, Moxon, E, Yu, L, Pollard, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2009
|
Registos relacionados
-
PECULIARITIES OF CULTIVATION OF HAEMOPHILUS INFLUENZAE TYPE B STRAINS - PRODUCERS OF POLYRIBOSYLRIBITOL PHOSPHATE - THE MAIN COMPONENT OF POLYSACCHARIDE VACCINES
Por: E. L. Salimova, et al.
Publicado em: (2017-10-01) -
THE SAFETY OF HAEMOPHILUS INFLUENZAE TYPE B/POLYRIBOSYLRIBITOL PHOSPHATE-TETANUS (HIB/PRP-T) VACCINE, PHASE I STUDY
Por: Kusnandi Rusmil, et al.
Publicado em: (2015-09-01) -
Enzyme-linked Immunosorbent Assay (ELISA) for Measurement of Antibody against Polyribosylribitol Phosphate Polysaccharide Capsule Extracted from Haemophilus Influenza Type-B Strain-Atf2
Por: Shafagh Khademi, et al.
Publicado em: (2016-05-01) -
Haemophilus influenzae type b conjugate vaccines
Por: Kelly, D, et al.
Publicado em: (2004) -
Haemophilus influenzae type b conjugate vaccines.
Por: Kelly, D, et al.
Publicado em: (2004)